Clinical Trials Logo

Gastric Mixed Adenocarcinoma clinical trials

View clinical trials related to Gastric Mixed Adenocarcinoma.

Filter by:
  • Completed  
  • Page 1

NCT ID: NCT01260701 Completed - Clinical trials for Adenocarcinoma of the Gastroesophageal Junction

Akt Inhibitor MK2206 in Treating Patients With Advanced Gastric or Gastroesophageal Junction Cancer

Start date: January 2011
Phase: Phase 2
Study type: Interventional

This phase II clinical trial studies how well Akt inhibitor MK2206 works in treating patients with advanced gastric or gastroesophageal junction cancer. Akt inhibitor MK2206 may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth.